Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients

Microbes and Infection

Volumn 10, Issue 2, 2008, Pages 151-158

  Melles, Damian C ^a   Pauw, Erna ^a   van den Boogaard, Linda ^a   Boelens, Hélène A M ^a   Peters, Jenny ^b   Peeters, Justine K ^a   Witsenboer, Hanneke ^b   van Leeuwen, Willem B ^a   Verbrugh, Henri A ^a   van Belkum, Alex ^a   Nouwen, Jan L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b KEYGENE N V   (Netherlands)

Author keywords

Highly active antiretroviral therapy; Human immunodeficiency virus; Nasal carriage; Panton Valentine leukocidin; PCP prophylaxis; Staphylococcus aureus

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC SCREENING; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; NOSE SMEAR; OUTPATIENT DEPARTMENT; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKING; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AMBULATORY CARE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTI-HIV AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CARRIER STATE; CHEMOPREVENTION; CLUSTER ANALYSIS; DNA, BACTERIAL; EXOTOXINS; FEMALE; HIV INFECTIONS; HUMANS; LEUKOCIDINS; MALE; MIDDLE AGED; NETHERLANDS; NOSE; PNEUMONIA, PNEUMOCYSTIS; RISK FACTORS; SEX FACTORS; SMOKING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS JIROVECII; STAPHYLOCOCCUS AUREUS;

EID: 39749117530     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.10.017     Document Type: Article

References (33)

1. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., and Nouwen J.L. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5 (2005) 751-762
2. von Eiff C., Becker K., Machka K., Stammer H., and Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group, N. Engl. J. Med. 344 (2001) 11-16
3. Reagan D.R., Doebbeling B.N., Pfaller M.A., Sheetz C.T., Houston A.K., Hollis R.J., and Wenzel R.P. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann. Intern. Med. 114 (1991) 101-106
4. Parras F., Guerrero M.C., Bouza E., Blazquez M.J., Moreno S., Menarguez M.C., and Cercenado E. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother 39 (1995) 175-179
5. Casewell M.W., and Hill R.L. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ("pseudomonic acid")-a controlled trial. J. Antimicrob. Chemother 17 (1986) 365-372
6. Kluytmans J., van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10 (1997) 505-520
7. Amir M., Paul J., Batchelor B., Kariuki S., Ojoo J., Waiyaki P., and Gilks C. Nasopharyngeal carriage of Staphylococcus aureus and carriage of tetracycline-resistant strains associated with HIV-seropositivity. Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 34-40
8. Sissolak D., Geusau A., Heinze G., Witte W., and Rotter M.L. Risk factors for nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains. Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002) 88-96
9. Miller M., Cespedes C., Vavagiakis P., Klein R.S., and Lowy F.D. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur. J. Clin. Microbiol. Infect. Dis. 22 (2003) 463-469
10. Weinke T., Schiller R., Fehrenbach F.J., and Pohle H.D. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 11 (1992) 985-989
11. Ganesh R., Castle D., McGibbon D., Phillips I., and Bradbeer C. Staphylococcal carriage and HIV infection. Lancet 2 (1989) 558
12. Smith K.J., Wagner K.F., Yeager J., Skelton H.G., and Ledsky R. Staphylococcus aureus carriage and HIV-1 disease: association with increased mucocutaneous infections as well as deep soft-tissue infections and sepsis. Arch. Dermatol. 130 (1994) 521-522
13. Nguyen M.H., Kauffman C.A., Goodman R.P., Squier C., Arbeit R.D., Singh N., Wagener M.M., and Yu V.L. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann. Intern. Med. 130 (1999) 221-225
14. Senthilkumar A., Kumar S., and Sheagren J.N. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 33 (2001) 1412-1416
15. VandenBergh M.F., Yzerman E.P., van Belkum A., Boelens H.A., Sijmons M., and Verbrugh H.A. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J. Clin. Microbiol. 37 (1999) 3133-3140
16. Eriksen N.H., Espersen F., Rosdahl V.T., and Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol. Infect. 115 (1995) 51-60
17. Nouwen J.L., Ott A., Kluytmans-Vandenbergh M.F., Boelens H.A., Hofman A., van Belkum A., and Verbrugh H.A. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule". Clin. Infect. Dis. 39 (2004) 806-811
18. Hu L., Umeda A., Kondo S., and Amako K. Typing of Staphylococcus aureus colonising human nasal carriers by pulsed-field gel electrophoresis. J. Med. Microbiol. 42 (1995) 127-132
19. Nouwen J., Boelens H., van Belkum A., and Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect. Immun. 72 (2004) 6685-6688
20. White A. Quantitative studies of nasal carriers of staphylococci among hospitalized patients. J. Clin. Invest. 40 (1961) 23-30
21. Nouwen J.L., Fieren M.W., Snijders S., Verbrugh H.A., and van Belkum A. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int. 67 (2005) 1084-1092
22. Melles D.C., Gorkink R.F., Boelens H.A., Snijders S.V., Peeters J.K., Moorhouse M.J., van der Spek P.J., van Leeuwen W.B., Simons G., Verbrugh H.A., and van Belkum A. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J. Clin. Invest. 114 (2004) 1732-1740
23. Murakami K., Minamide W., Wada K., Nakamura E., Teraoka H., and Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29 (1991) 2240-2244
24. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., Vandenesch F., and Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29 (1999) 1128-1132
25. Reijans M., Lascaris R., Groeneger A.O., Wittenberg A., Wesselink E., van Oeveren J., de Wit E., Boorsma A., Voetdijk B., van der Spek H., Grivell L.A., and Simons G. Quantitative comparison of cDNA-AFLP, microarrays, and GeneChip expression data in Saccharomyces cerevisiae. Genomics 82 (2003) 606-618
26. Bogaert D., van Belkum A., Sluijter M., Luijendijk A., de Groot R., Rumke H.C., Verbrugh H.A., and Hermans P.W. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363 (2004) 1871-1872
27. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur. J. Epidemiol. 7 (1991) 403-422
28. J. Nouwen, A. Ott, H. Boelens, M. Claassen, A. van Belkum, A. Hofman, H.A. Verbrugh, Smoking pattern and fasting glucose levels determine Staphylococcus aureus nasal carriage. PhD thesis, Erasmus University Medical Center, Rotterdam, The Netherlands, 2004.
29. van Leeuwen W.B., Jay C., Snijders S., Durin N., Lacroix B., Verbrugh H.A., Enright M.C., Troesch A., and van Belkum A. Multilocus sequence typing of Staphylococcus aureus with DNA array technology. J. Clin. Microbiol. 41 (2003) 3323-3326
30. Miller M., Cespedes C., Bhat M., Vavagiakis P., Klein R.S., and Lowy F.D. Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users. Clin. Infect. Dis. 45 (2007) 343-346
31. Kuehnert M.J., Kruszon-Moran D., Hill H.A., McQuillan G., McAllister S.K., Fosheim G., McDougal L.K., Chaitram J., Jensen B., Fridkin S.K., Killgore G., and Tenover F.C. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J. Infect. Dis. 193 (2006) 172-179
32. Wertheim H.F., Vos M.C., Boelens H.A., Voss A., Vandenbroucke-Grauls C.M., Meester M.H., Kluytmans J.A., Van Keulen P.H., and Verbrugh H.A. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J. Hosp. Infect. 56 (2004) 321-325
33. Melles D.C., van Leeuwen W.B., Boelens H.A., Peeters J.K., and Verbrugh H.A. A. van Belkum, Panton-Valentine leukocidin genes in Staphylococcus aureus. Emerg. Infect. Dis. 12 (2006) 1174-1175